MUCOLIPIDOSIS TYPE IV
Clinical trials for MUCOLIPIDOSIS TYPE IV explained in plain language.
Never miss a new study
Get alerted when new MUCOLIPIDOSIS TYPE IV trials appear
Sign up with your email to follow new studies for MUCOLIPIDOSIS TYPE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First gene therapy trial launches for rare childhood disease MLIV
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a gene therapy called AAV9.hMCOLN1co in one child with Mucolipidosis Type IV (MLIV), a rare genetic disorder. The therapy is given as a single injection into the spinal fluid. The main goal is to check safety, but researchers will also look for any si…
Matched conditions: MUCOLIPIDOSIS TYPE IV
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New study tracks rare disease MLIV to map its natural course
Knowledge-focused OngoingThis study looks back at medical records of 50 people with Mucolipidosis Type IV (MLIV) to learn how the disease typically progresses. Researchers want to know when children reach or lose developmental milestones, how their movement and vision change, and what lab results look li…
Matched conditions: MUCOLIPIDOSIS TYPE IV
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC